肿瘤相关中性粒细胞与胰腺癌关系的研究进展

doi:10.11904/j.issn.1002-3070.2022.05.012

实用肿瘤学杂志 ›› 2022, Vol. 36 ›› Issue (5): 458-462.doi: 10.11904/j.issn.1002-3070.2022.05.012

肿瘤相关中性粒细胞与胰腺癌关系的研究进展

李雄¹, 姜文凯², 郎泽昆² 综述, 芮少珍³ 审校

1.兰州大学第二临床医学院(兰州 730000);
2.兰州大学第一临床医学院;
3.兰州大学第一医院普外科

收稿日期:2022-07-29 修回日期:2022-10-08 出版日期:2022-10-28 发布日期:2022-11-10
通讯作者: 芮少珍,E-mail:ruishaozhen@163.com
作者简介:李雄,男,(2001-),本科在读,从事胰腺癌的基础研究。
基金资助:
兰州大学第一医院院内基金(编号:ldyyyn2019-69)

Research progress on the relationship between tumor-associated neutrophils and pancreatic cancer

LI Xiong¹, JIANG Wenkai², LANG Zekun², RUI Shaozhen³

1. The Second Clinical Medical College of Lanzhou University,Lanzhou 730000,China;
2. The First Clinical Medical College of Lanzhou University;
3. Department of General Surgery,The First Hospital of Lanzhou University

Received:2022-07-29 Revised:2022-10-08 Online:2022-10-28 Published:2022-11-10

摘要/Abstract

摘要： 胰腺癌是一种起病隐匿、预后不良的消化系统恶性肿瘤,具有早期诊断困难、进展期生存时间短等特点。胰腺癌的肿瘤微环境(Tumor microenvironment,TME)中常常伴有大量免疫细胞的浸润,而肿瘤相关中性粒细胞(Tumor-associated neutrophils,TANs)作为TME的重要组成部分,在肿瘤的进程中起着重要作用。相关研究表明,TANs在胰腺癌的TME中发挥多种作用。本文从TANs与胰腺癌的关系进行综述,为理解胰腺癌发生机制与提出新疗法提供思路。

关键词: 胰腺癌, 肿瘤相关中性粒细胞, 肿瘤微环境, 免疫治疗

Abstract: Pancreatic cancer is a malignant tumor of digestive system with hidden onset and poor prognosis,which is characterized by difficult early diagnosis and short survival time in the advanced stage.The tumor microenvironment(TME)of pancreatic cancer is often accompanied by the infiltration of a large number of immune cells.As an important part of the TEM,tumor-associated neutrophils(TANs)play an important role in the process of tumor.Relevant studies have shown that TANs play multiple roles in the TME of pancreatic cancer.This article reviews the relationship between TANs and pancreatic cancer to provide ideas for understanding the pathogenesis of pancreatic cancer and proposing new therapies.

Key words: Pancreatic cancer, Tumor-associated neutrophils, Tumor microenvironment, Immunotherapy

中图分类号:

R735.9

李雄, 姜文凯, 郎泽昆, 芮少珍. 肿瘤相关中性粒细胞与胰腺癌关系的研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 458-462.

LI Xiong, JIANG Wenkai, LANG Zekun, RUI Shaozhen. Research progress on the relationship between tumor-associated neutrophils and pancreatic cancer[J]. Journal of Practical Oncology, 2022, 36(5): 458-462.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.05.012

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I5/458

参考文献

1 Wu M,Ma M,Tan Z,et al.Neutrophil:a new player in metastatic cancers[J].Front Immunol,2020,11:565165.
2 Park W,Chawla A,O'Reilly EM.Pancreatic cancer:a review[J].JAMA,2021,326(9):851-862.
3 Bejarano L,Jordāo MJC,Joyce JA.Therapeutic targeting of the tumor microenvironment[J].Cancer Discov,2021,11(4):933-959.
4 Propper DJ,Balkwill FR.Harnessing cytokines and chemokines for cancer therapy[J].Nat Rev Clin Oncol,2022,19(4):237-253.
5 Weber R,Groth C,Lasser S,et al.IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy[J].Cell Immunol,2021,359:104254.
6 韩帮岭,汪亦民,薛英威.中性粒细胞与恶性肿瘤关系的研究进展[J].实用肿瘤学杂志,2018,32(4):349-352.
7 Jaillon S,Ponzetta A,Di Mitri D,et al.Neutrophil diversity and plasticity in tumour progression and therapy[J].Nat Rev Cancer,2020,20(9):485-503.
8 Mizuno R,Kawada K,Itatani Y,et al.The role of tumor-associated neutrophils in colorectal cancer[J].Int J Mol Sci,2019,20(3):529.
9 Ronchetti L,Boubaker NS,Barba M,et al.Neutrophil extracellular traps in cancer:not only catching microbes[J].J Exp Clin Cancer Res,2021,40(1):231.
10 Cristinziano L,Modestino L,Antonelli A,et al.Neutrophil extracellular traps in cancer[J].Semin Cancer Biol,2022,79:91-104.
11 Mihaila AC,Ciortan L,Macarie RD,et al.Transcriptional profiling and functional analysis of N1/N2 neutrophils reveal an immunomodulatory effect of S100A9-Blockade on the pro-inflammatory N1 subpopulation[J].Front Immunol,2021,12:708770.
12 Andzinski L,Kasnitz N,Stahnke S,et al.Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human[J].Int J Cancer,2016,138(8):1982-1993.
13 Dou A,Fang J.Heterogeneous myeloid cells in tumors[J].Cancers(Basel),2021,13(15):3772.
14 Ohms M,Möller S,Laskay T.An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro[J].Front Immunol,2020,11:532.
15 梁立洲,邓振沣,金宗睿,等.肿瘤相关中性粒细胞释放APRIL对胰腺癌细胞增殖活性的影响[J].中国普外基础与临床杂志,2020,27(8):940-944.
16 Schoeps B,Eckfeld C,Prokopchuk O,et al.TIMP1 triggers neutrophil extracellular trap formation in pancreatic cancer[J].Cancer Res,2021,81(13):3568-3579.
17 Miller-Ocuin JL,Liang X,Boone BA,et al.DNA released from neutrophil extracellular traps(NETs)activates pancreatic stellate cells and enhances pancreatic tumor growth[J].Oncoimmunology,2019,8(9):e1605822.
18 Korc M.Pancreatic cancer-associated stroma production[J].Am J Surg,2007,194(4 Suppl.1):84-86.
19 Deng J,Kang Y,Cheng CC,et al.DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis[J].JCI Insight,2021,6(16):e146133.
20 Kajioka H,Kagawa S,Ito A,et al.Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis[J].Cancer Lett,2021,497:1-13.
21 Takesue S,Ohuchida K,Shinkawa T,et al.Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer-associated fibroblasts[J].Int J Oncol,2020,56(2):596-605.
22 Tamassia N,Bianchetto-Aguilera F,Arruda-Silva F,et al.Cytokine production by human neutrophils:revisiting the "dark side of the moon"[J].Eur J Clin Invest,2018,48(Suppl 2):e12952.
23 Chao T,Furth EE,Vonderheide RH.CXCR2-dependent accumulation of tumor-associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma[J].Cancer Immunol Res,2016,4(11):968-982.
24 Zhang Y,Chandra V,Riquelme Sanchez E,et al.Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer[J].J Exp Med,2020,217(12):e20190354.
25 Bausch D,Pausch T,Krauss T,et al.Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma[J].Angiogenesis,2011,14(3):235-243.
26 Li A,King J,Moro A,et al.Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer[J].Am J Pathol,2011,178(3):1340-1349.
27 Matsuo Y,Ochi N,Sawai H,et al.CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer[J].Int J Cancer,2009,124(4):853-861.
28 姜文凯,周文策,李昕.外泌体miRNA与胰腺癌关系的研究进展[J].现代肿瘤医学,2021,29(7):1267-1270.
29 Bellomo G,Rainer C,Quaranta V,et al.Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis[J].Gut,2022,71(11):2284-2299.
30 Phan VT,Wu X,Cheng JH,et al.Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment[J].Proc Natl Acad Sci U S A,2013,110(15):6079-6084.
31 Siolas D,Vucic E,Kurz E,et al.Gain-of-function p53(R172H)mutation drives accumulation of neutrophils in pancreatic tumors,promoting resistance to immunotherapy[J].Cell Rep,2021,36(8):109578.
32 Purohit A,Saxena S,Varney M,et al.Host Cxcr2-dependent regulation of pancreatic cancer growth,angiogenesis,and metastasis[J].Am J Pathol,2021,191(4):759-771.
33 Zhang M,Huang L,Ding G,et al.Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer[J].J Immunother Cancer,2020,8(1):e000308.
34 Nielsen SR,Strøbech JE,Horton ER,et al.Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade[J].Nat Commun,2021,12(1):3414.
35 Jin W,Yin H,Li H,et al.Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR/ERK pathway[J].J Cell Mol Med,2021,25(12):5443-5456.
36 Abdol Razak N,Elaskalani O,Metharom P.Pancreatic cancer-induced neutrophil extracellular traps:a potential contributor to cancer-associated thrombosis[J].Int J Mol Sci,2017,18(3):487.
37 刘金爽,张文静,黎清炜,等.免疫检查点抑制剂的联合治疗在胰腺癌中的研究进展[J].实用肿瘤学杂志,2022,36(1):49-53.
38 楼文晖.胰腺癌精准治疗现状、挑战和未来[J].中国实用外科杂志,2021,41(9):1014-1016.

[1]	孙阜圣, 徐冶, 张永健, 娄阁. 卵巢癌类器官模型的研究进展和治疗新策略[J]. 实用肿瘤学杂志, 2022, 36(4): 346-350.
[2]	刘欣欣, 姚欣卉, 孙跃峰, 缪美琪, 陈晶. 乳腺癌微环境中趋化因子CCL20作用的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 250-254.
[3]	童曼琳, 尚茹茹, 刘晓红. PD-1/PD-L1免疫检查点抑制剂在多形性胶质母细胞瘤中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 278-282.
[4]	吴芳芳, 郑桐森. 胆道恶性肿瘤辅助治疗的研究现状及展望[J]. 实用肿瘤学杂志, 2022, 36(2): 156-161.
[5]	刘雨, 俞星新, 耿志达, 陈政良, 惠鹏, 梁英健. 成纤维细胞在肝癌发生发展中的作用[J]. 实用肿瘤学杂志, 2022, 36(2): 167-172.
[6]	唐菊, 尚利华. BMI与免疫检查点抑制剂治疗恶性肿瘤疗效的关系[J]. 实用肿瘤学杂志, 2022, 36(2): 188-192.
[7]	刘金爽, 张文静, 黎清炜, 李志伟. 免疫检查点抑制剂的联合治疗在胰腺癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(1): 49-53.
[8]	董丽娜, 梁田, 张献, 张广美. 卵巢癌对富脂大网膜的器官趋向性转移的研究进展[J]. 实用肿瘤学杂志, 2022, 36(1): 54-58.
[9]	张文静, 刘金爽, 王丹, 黎清炜, 李志伟. 胰腺癌新辅助治疗的研究现状[J]. 实用肿瘤学杂志, 2022, 36(1): 64-68.
[10]	牟冠男, 马强. NK细胞极化在子宫内膜癌中的作用[J]. 实用肿瘤学杂志, 2021, 35(6): 534-537.
[11]	杨开炎, 韦永昌, 杨秋云, 唐凤珠. 鼻咽癌的免疫治疗研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 542-546.
[12]	李响, 胡洋, 张清媛. 肿瘤突变负荷作为乳腺癌免疫治疗的新兴生物标志物的研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 568-571.
[13]	隆园辉, 陈雪松. 心理应激对肿瘤微环境中免疫细胞影响的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 436-440.
[14]	王亮亮, 丁高恒, 陈莉莉, 吴建军, 刘玉琴, 魏兴民. 2009—2015年甘肃省肿瘤登记地区胰腺癌流行特征及变化趋势分析[J]. 实用肿瘤学杂志, 2021, 35(3): 200-206.
[15]	马明瑞, 连洁, 刘超, 娄长杰, 张艳桥. 消化系统肿瘤“免疫治疗前移”的探索[J]. 实用肿瘤学杂志, 2021, 35(3): 258-262.

肿瘤相关中性粒细胞与胰腺癌关系的研究进展

Research progress on the relationship between tumor-associated neutrophils and pancreatic cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价